Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page’s software/document revision indicator was updated from v3.5.2 to v3.5.3, reflecting a backend/version change rather than a modification to the study record content.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded page revision details for v3.5.2 with April 2026 dates and removed references to v3.5.0.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3. This update appears to modify internal versioning information and does not change displayed content.SummaryDifference0.1%

- Check46 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. There are no observable changes to study details or core content.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 and removed the older notices, including the lapse in government funding message and Revision: v3.4.1.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded a government funding lapse notice warning of possible delays in updating information and directing users to cc.nih.gov and opm.gov for status. Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.